Nanjing YDB Medical Technology Co., Ltd. was established in October 2013 with a registered capital of  RMB 100 million. The company is located in Nanjing Gaochun Economic Development Zone. It is a high-end medical device supplier specializing in cardio-cerebrovascular and pan-vascular interventions, as well as interventional stroke prevention.

The company integrates R&D, production, and marketing into a single entity. It has obtained ISO 13485 Quality Management System certification. The company has been awarded the titles of national "High-Tech Enterprise," "Jiangsu Province Specialized, Refined, Distinctive and Innovative SME (SRDI)," "Jiangsu Province Gazelle Enterprise," "Nanjing Outstanding Private Enterprise," "Nanjing Certified Enterprise Technology Center," and "Nanjing Engineering Technology Research Center." The company has also secured approvals for provincial and municipal science and technology project initiatives.

Dedicated to "intervention without implantation," the company focuses on high-value consumables in the pan-vascular domain. It currently has a total of 8 Class II and 17 Class III products commercially available, and 9 Class III products in the pipeline. The company holds more than 60 granted patents, and has over 40 patent applications that have been accepted and are pending grant.

As a leading medical device enterprise brought in under the Nanjing Gaochun District Government's key investment initiative, the company secured a 100-mu land parcel (approximately 6.67 hectares) in the Gaochun Development Zone in 2018 to build a 100,000-square-meter R&D and manufacturing facility for its "Pan-Vascular Medical Device Project." The company is committed to advancing treatments for acute and chronic coronary artery disease, prevention of cardioembolic stroke, ischemic stroke therapy, and related therapeutic areas.